Invention Grant
- Patent Title: Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation
-
Application No.: US15128714Application Date: 2015-03-26
-
Publication No.: US10426782B2Publication Date: 2019-10-01
- Inventor: Rachael L. Brake , Viviana Bozon , Ching-Kuo J. Chow , James C. Dinunzio , Katherine M. Galvin , Karuppiah Kannan , Yuki Kodono , Qunli Xu
- Applicant: Millennium Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: MILLENNIUM PHARMACEUTICALS, INC.
- Current Assignee: MILLENNIUM PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: PK162/2015 20150325; UY36.046 20150325
- International Application: PCT/US2015/022792 WO 20150326
- International Announcement: WO2015/148828 WO 20151001
- Main IPC: A61K31/541
- IPC: A61K31/541 ; A61K9/14 ; A61K9/20 ; C12Q1/6886 ; A61K9/28
Abstract:
The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen.
Public/Granted literature
Information query
